Monoclonal antibodies against CD54 (ICAM-1) and CD11a (LFA-1) prevent and inhibit endotoxin-induced uveitis
- 1 June 1995
- journal article
- Published by Elsevier in Experimental Eye Research
- Vol. 60 (6) , 597-601
- https://doi.org/10.1016/s0014-4835(05)80001-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Efficacy of antibodies to adhesion molecules, CDlla or CD18, in rabbit models of uveitisCurrent Eye Research, 1993
- ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats.The Journal of Immunology, 1991
- Production of interleukin-1-receptor antagonist during experimental endotoxaemiaThe Lancet, 1991
- Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists.The Journal of Immunology, 1991
- Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA‐1 subunit‐specific monoclonal antibodiesEuropean Journal of Immunology, 1991
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.Journal of Clinical Investigation, 1989
- Endotoxin-induced uveitis in the ratAlbrecht von Graefes Archiv für Ophthalmologie, 1988
- Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).The Journal of Immunology, 1986
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Endotoxin-induced uveitis in rats as a model for human diseaseNature, 1980